Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin

[1]  H. Bundgaard,et al.  Potassium depletion increases potassium clearance capacity in skeletal muscles in vivo during acute repletion. , 2002, American journal of physiology. Cell physiology.

[2]  A. McDonough,et al.  Glucocorticoids increase sodium pump α2- and β1-subunit abundance and mRNA in rat skeletal muscle , 2001 .

[3]  G. Daugaard,et al.  Cisplatin and hypomagnesemia. , 1999, Cancer treatment reviews.

[4]  T. Clausen.  Clinical and therapeutic significance of the Na+,K+ pump*. , 1998, Clinical science.

[5]  R. Rude.  Magnesium metabolism and deficiency. , 1993, Endocrinology and metabolism clinics of North America.

[6]  E. Vokes,et al.  A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia. , 1990, British Journal of Cancer.

[7]  N. Holstein-Rathlou,et al.  Renal tubular function in patients treated with high‐dose cisplatin , 1988, Clinical pharmacology and therapeutics.

[8]  T. Clausen,et al.  A simple and rapid method for the determination of the concentrations of magnesium, sodium, potassium and sodium, potassium pumps in human skeletal muscle. , 1988, Clinical science.

[9]  K. Kjeldsen,et al.  Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics , 1988, British medical journal.

[10]  R. Elin.  Assessment of magnesium status. , 1987, Clinical chemistry.

[11]  K. Kjeldsen.  Complete quantification of the total concentration of rat skeletal-muscle Na+ + K+-dependent ATPase by measurements of [3H]ouabain binding. , 1986, The Biochemical journal.

[12]  G. Quamme,et al.  Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats. , 1985, Kidney international.

[13]  A. F. Stewart,et al.  Magnesium homeostasis following chemotherapy with cisplatin: a prospective study. , 1985, American journal of obstetrics and gynecology.

[14]  R. Edwards,et al.  MUSCLE-BIOPSY NEEDLES , 1979, The Lancet.

[15]  J C SKOU,et al.  ENZYMATIC BASIS FOR ACTIVE TRANSPORT OF NA+ AND K+ ACROSS CELL MEMBRANE. , 1965, Physiological reviews.

[16]  M. Kelly.  The postoperative chest. , 1964, Lancet.

[17]  E. Newlands,et al.  Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy , 2004, Cancer Chemotherapy and Pharmacology.

[18]  A. McDonough,et al.  Glucocorticoids increase sodium pump alpha(2)- and beta(1)-subunit abundance and mRNA in rat skeletal muscle. , 2001, American Journal of Physiology - Cell Physiology.

[19]  G. Ariceta,et al.  Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis. , 1997, Medical and pediatric oncology.

[20]  J. Mansi,et al.  A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil. , 1995, European journal of cancer.

[21]  K. Kjeldsen,et al.  Effect of magnesium depletion on 3H-ouabain binding site concentration in rat skeletal muscle. , 1987, Magnesium.